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http://dx.doi.org/10.1016/j.pedneo.2Background: Sexual dimorphism plays a role in the liver and in renal injuries. However,
whether sex is a risk factor in bile duct ligation (BDL) in young rats has never been examined.
Methods: Six male and six female rats treated with BDL were sacrificed 2 weeks after surgery
and were designated as BDL-M and BDL-F groups. The other six male and six female rats that
received sham ligation were designated as sham-M and sham-F groups. Plasma biochemistry
and liver and kidney asymmetric dimethylarginine (ADMA)-related molecules were examined.
Results: Both BDL-M and BDL-F groups had elevated plasma aspartate transaminase (AST),
alanine transaminase (ALT), bilirubin, and transforming growth factor-b1 levels. The BDL-F
group had lower plasma AST and ALT levels than the BDL-M group. The BDL-M and BDL-F groups
had elevated plasma ADMA levels. The cationic amino acid transporter 1 (CAT1) level was
increased in the BDL-F group as compared to the sham-F group, whereas the CAT2 level was
reduced in the both BDL-M and BDL-F groups.
Conclusion: We found that young male rats were prone to higher degrees of biochemical liver
and kidney injury to cholestasis. Sex differences in modulation of oxidative stress markers,of Pediatrics, Chang Gung Memorial Hospital-Kaohsiung, 123 Ta-Pei Road, Niao-Sung, Kaohsiung 833,
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96 K.-A. Chang et alsuch as ADMA, may play a role. Our results support careful monitoring and optimal treatment
of cholestatic disease, especially in young male patients.
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reserved.1. Introduction
Cholestasis is defined as impairment of bile secretion
caused by dysfunction of hepatocytes and/or bile duct
epithelium, or a blockade to free bile flow. It may manifest
with varying degrees of jaundice, pruritus, and elevated
serum levels of alkaline phosphatase, g-glutamyl trans-
peptidase, bile acids, and cholesterol.1
Human cholestasis may be induced by drugs, obstructive
cholestasis, primary biliary cirrhosis, sepsis-induced chole-
stasis, and extrahepatic biliary atresia.1 Sex differences
were noted in the response of the liver under various types
of stress. Fibrosis progression is slower in females with
human hepatitis C, human hepatitis B, genetic hemochro-
matosis, and primary biliary cirrhosis, but more rapid in
females with alcoholic liver disease in comparison with
males2,3; however, the mechanism is still not well
understood.
There are many experimental models of intrahepatic
cholestasis, including estrogen-induced, endotoxin-
induced, drug-induced cholestasis and bile duct ligation
(BDL).1,4 Sexual dimorphism was also reported in a BDL
model.5 We previously found that there were progressive
liver and kidney injuries in young rats treated with BDL.
Hence, we are interested in whether sexual dimorphism
exists in the BDL-treated young rat model.
Cholestasis is now regarded as a disorder of oxidant
overload of the liver and it has systemic effects.6,7
Increased oxidative stress has been proposed as the main
mechanism underlying endothelial dysfunction.8 Asym-
metric dimethylarginine (ADMA) is an endothelium nitric
oxide synthase (eNOS) inhibitor that can reduce nitric oxide
(NO) production and is considered preoxidant.9,10 Increased
plasma ADMA levels have been found in patients with
cirrhosis and rats treated with BDL.9,10 We also found
previously that there was progressive liver and kidney
injury in young rats treated with BDL, which was associated
with increased ADMA and oxidative stress.11
Protein-incorporated ADMA is formed by the protein
arginine methyltransferases (PRMTs); two methyl groups
are added on one of the terminal nitrogen atoms of the
guanidine group of arginine in proteins.12 Free ADMA is
released after proteolysis. Free ADMA can be transported in
or out of cells via the cationic amino acid transporter
family. Excess circulating ADMA can be transported to
major organs, such as the kidney and liver, for ADMA
degradation.12
In this study, we aimed to explore the sex difference of
BDL-induced cholestasis in young rats, focusing on liver
and renal damage. In this context, we examined the role
of ADMA and ADMA-related enzymes in the development
of cholestatic liver disease-induced liver and kidney
injuries.2. Materials and Methods2.1. Animals
This experiment was performed according to the Guide-
lines for Animal Experiments of Kaohsiung Chang Gung
Memorial Hospital and Chang Gung University. Male and
female Sprague-Dawley rats on postnatal day 17  1,
weighing approximately 50 g, were used. All rats were
housed in a room maintained at 24C with 12-hour light/
dark cycles and received food and water ad libitum.2.2. Experimental protocols
All surgical procedures were performed under ketamine
(50 mg/kg) and xylazine (23 mg/kg) anesthesia with
clean surgical techniques as previously described.13 The
rats receiving BDL were induced via midline incision and
the common bile duct was ligated and divided with
double ligatures of the proximal duct. Six male and six
female rats treated with BDL were sacrificed 2 weeks
after surgery and were designated as BDL-M and BDL-F
groups. The other six male and six female rats received
sham ligation of the bile duct and were sacrificed 2
weeks after the surgery, designated as sham-M and sham-
F groups.2.3. General plasma biochemical analysis
The liver function parameters aspartate transaminase
(AST), alanine transaminase (ALT), and direct and total
bilirubin levels were measured using an automated method
as described previously.13 Transforming growth factor-b1
(TGF-b1) levels were analyzed using a TGF-b1 Emax
immunoassay (G7590; Promega, Fitchburg, USA). Creatinine
levels were analyzed with high-performance liquid chro-
matography (HPLC), as described previously.112.4. Determination of L-citrulline, L-arginine,
asymmetric dimethylarginine, and symmetric
dimethylarginine using high-performance liquid
chromatography
Plasma L-citrulline (L-Cit), L-arginine (L-Arg), ADMA, and
symmetric dimethylarginine (SDMA, a stereoisomer of
ADMA) and ADMA levels of the liver and kidney were
measured using HPLC (HP series 1100, Agilent Technologies,
Inc., Santa Clara, CA, USA) with the OPA-3MPA derivatiza-
tion reagent as described previously.14
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Pathology was assessed on 4-mm sections of formalin-fixed
liver and kidney, which were blocked in paraffin wax and
stained with periodic acid-Schiff stain. Liver injury was
assessed by hematoxylin and eosin staining using a histology
activity index (HAI) score.15 The HAI score examined liver
cell necrosis and inflammation in four categories: periportal
necrosis, intralobular necrosis, portal inflammation, and
fibrosis. Renal injury was evaluated by tubulointerstitial
injury (TI), which was graded (0e5) based on the presence
of tubular cellularity, basement membrane thickening,
dilation, atrophy, sloughing, or interstitial widening, as
follows: 0, no changes present; grade 1, <10%; grade 2,
10e25%; grade 3, 25e50%; grade 4, 50e75%; and grade 5,
75e100% TI involvement.16
2.6. Western blot
Protein arginine methyltransferase-1 (PRMT1) is the
predominant type 1 PRMT isoenzyme responsible for ADMA
synthesis. Therefore, we studied the level of PRMT1 in the
liver and kidney. Western blot analysis was conducted as
described previously.17 Briefly, measurement was con-
ducted on the kidney and liver (100e200 mg total protein).
We used a rabbit anti-PRMT1 antibody (Millipore, Billerica,
MA, USA; 1:2000 dilution, overnight incubation) and a goat
antirabbit antibody. Bands of interest were visualized using
ECL reagents (PerkinElmer, Waltham, MA, USA) and quan-
tified by densitometry (Quantity One Analysis software;
Bio-Rad, Hercules, CA, USA) as integrated optical density
(IOD) after subtraction of background. The IOD was
factored for Ponceau S staining to correct for any variations
in total protein loading. The protein abundance was rep-
resented as IOD/PonS.17
2.7. Quantitative real-time PCR analysis of liver and
kidney
RNA was extracted using TRI Reagent (Sigma-Aldrich,
St. Louis, MO, USA), treated with DNase I (Ambion, Austin,
TX, USA) to remove DNA contamination, and 2 mgwas reverse
transcribed (SuperScript II RNase He Reverse Transcriptase,
Invitrogen, Bethesda, MD, USA) with random primers (Invi-
trogen) in a total volume of 40 mL as we previously
described.18 Control reverse transcription (RT) reactions
were performed by omitting the RT enzyme, and PCR was
amplified to ensure that DNA did not contaminate the RNA.
Two-step quantitative real-time PCR was conducted using
Quantitect SYBR Green PCR Reagents (Qiagen, Valencia, CA,
USA) according to the manufacturer’s protocol on a Light-
Cycler Real-Time PCR System (Roche Diagnostics Ltd., Tai-
pei, Taiwan). b-Actin served as a housekeeping gene. For
cationic amino acid transporter 1 (CAT1), a forward primer
5’-AGCCCAGGAGAG
ATGAAA-3’ and a reverse primer 5’-TCAAGGAACGCAAAGGTA
AC-3’ were designed from rat-specific sequences
(NM_013111). For cationic amino acid transporter 2 (CAT-2),
a forwardprimer 5’-CTGGGAGTTGGAAGCAC-3’ anda reverse
primer 5’-CGATGAGGAAAGACACCACAATA-3’ were designed
from rat-specific sequences (NM_022619). All samples wererun in duplicate (2.5 mL of complementary DNA/well in a 96-
well format). For the relative quantification of gene
expression, the comparative threshold cycle (CT) method
was used. The averaged CT was subtracted from the corre-
sponding averaged b-actin value for each sample, resulting in
OCT.
OOCT was achieved by subtracting the average control
OCT value from the average experimental
OCT. The fold
increase was established by calculating 2OOCT for exper-
imental versus control samples.17
2.8. Statistical analysis
Results were presented as mean  standard error of the
mean. Morphologic and biochemical variables were
analyzed by one-way analysis of variance with the post hoc
least significant difference test. All analyses were per-
formed using the Statistical Package for the Social Sciences
(SPSS) software version 13, IBM Corporation. Significance
was defined as p < 0.05 for all tests.
3. Results
3.1. General morphologic features and
biochemistry
As shown in Table 1, both BDL-M and BDL-F groups had
decreased body weight and hepatomegaly (represented as
increased liver/body weight) compared with the sham
control groups; however, there was no significant differ-
ence between the BDL-M and BDL-F groups. Both BDL-M and
BDL-F groups also had elevated plasma AST, ALT, direct
bilirubin, total bilirubin, and TGF-b1 levels compared with
those in the sham groups. Notably, the BDL-F group had
significantly lower plasma AST and ALT levels than the BDL-
M group. The left kidney/body weight did not differ among
the four groups. The BDL-M group had significantly higher
creatinine levels than the sham-M group. Although both the
sham-F and BDL-F groups had significantly lower creatinine
levels than their male counterparts, there was no signifi-
cant difference of creatinine between sham-F and BDL-F
groups.
3.2. Pathology of liver and kidney
The HAI scores were 8.8  0.49 in BDL-M and 9.2  1.62 in
BDL-F groups, respectively. The TI scores were 0.53  0.10
in BDL-M and 0.37  0.10 in BDL-F groups, respectively.
There was no significant difference in either HAI or TI
scores between BDL-M and BDL-F groups.
3.3. Plasma L-arginine and ADMA levels
As shown in Table 2, the BDL-M and BDL-F groups had
significantly elevated plasma ADMA levels and SDMA levels
and decreased L-arginine/ADMA ratios as compared with
sham-M and sham-F groups. In addition, the BDL-M group
had higher ADMA values than the BDL-F group. There was no
difference of SDMA levels and L-arginine/ADMA ratios
between BDL-M and BDL-F groups. Furthermore, the BDL-M
group had significantly lower plasma L-arginine levels than
Table 1 Morphologic and plasma biochemical values in different experimental groups.
Sham-M BDL-M Sham-F BDL-F
(n Z 6) (n Z 6) (n Z 6) (n Z 6)
Body weight (g) 89.08  4.08 62.57  6.89* 94.23  4.76 66.32  7.33*
Left kidney weight (g) / 100 g body weight 0.70  0.03 0.78  0.02 0.67  0.03 0.76  0.03
Liver weight (g) / 100 g body weight (g) 4.62  0.12 7.44  0.45* 5.00  0.38 7.19  0.29*
Total bilirubin (mg/dL) 0.47  0.02 6.00  0.33* 0.30  0.04 6.55  0.12*
Direct bilirubin (mg/dL) 0.12  0.01 5.29  0.19* 0.11  0.01 5.47  0.18*
AST (IU/L) 108.67  6.63 905.83  105.25* 93.00  2.00 638.83  62.12*y
ALT (IU/L) 60.17  2.10 176.00  15.39* 51.50  1.86 123.33  7.51*y
Creatinine (mg/dL)* 0.41  0.04 0.59  0.05* 0.23  0.03y 0.31  0.03y
TGF-b1 (fg/mL)/protein concentration (pg/mL) 2.42  0.16 6.36  0.71* 2.43  0.25 4.66  0.35*y
Values are means  SEM.
*p < 0.05 compared with sham control of same gender, yp < 0.05 compared with male counterpart.
ALT Z alanine aminotransferase; AST Z aspartate aminotransferase; BDL-F Z bile duct ligation-female; BDL-M Z bile duct ligation-
male; Sham-F Z sham control-female; Sham-M Z sham control-male; TGF-b1 Z transforming growth factor b1.
* Creatinine level was analyzed by high-performance liquid chromatography.
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evident in female rats.
3.4. ADMA in the liver and kidney
Analysis of the liver (Figure 1) found that the BDL-M and
BDL-F groups had increased ADMA levels, compared to the
sham-M and sham-F groups. There was no significant
difference in ADMA between the BDL-M and the BDL-F
groups. Although analysis of the kidneys found that the
ADMA level had increased in the BDL-F group compared
with the sham-F group, there was no significant difference
between the BDL-M and sham-M groups.
3.5. ADMA-related enzymes in the liver and kidney
Analysis of the liver found that the PRMT1 expression was
significantly higher in both BDL-M and BDL-F groups in
comparison with the sham-M and sham-F groups (Figure 2).
There was no significant difference between the BDL-M and
BDL-F groups. Analysis of the kidneys showed that the
PRMT-1 level was increased in the BDL-F group when
compared with the sham-F group; there was no significantTable 2 Plasma L-citrulline, L-arginine, and dimethylarginine v
Sham-M BDL-M
(n Z 6) (n Z
L-Citrulline (mM) 72.55  14.70 53.56
L-Arginine (mM) 104.53  7.43 61.08
ADMA (mM) 0.36  0.03 0.70
SDMA (mM) 0.37  0.06 0.52
L-Arginine / ADMA ratio 293.52  28.30 89.89
ADMA / SDMA ratio 1.13  0.21 1.39
Values are means  standard error of the mean.
*p < 0.05 compared with sham control of same gender; yp < 0.05 co
ADMA Z asymmetric dimethylarginine; BDL-F Z bile duct ligation-fe
female; Sham-M Z sham control-male; SDMA Z symmetric dimethyladifference between the BDL-M and sham-M groups,
however. The CAT1 level was increased in the BDL-F group
when compared with the sham-F group; however, there was
no significant difference between BDL-M and BDL-F groups
(Figure 3). Although the CAT2 level was significantly
reduced in both the BDL-M and BDL-F groups, there was no
significant difference between the BDL-M and BDL-F groups.
The CAT2 expression was higher in the sham-F group in
comparison with the sham-M group. In the kidney, there
was no significant difference either in CAT1 or CAT2 among
the four groups (data not shown).4. Discussion
The major findings of this study were as follows: (1) the
BDL-F group had less liver function impairment and fewer
kidney injuries in comparison with the BDL-M group; (2) the
BDL-F group exhibited a smaller increase of plasma TGF-b1
level than the BDL-M group; and (3) the BDL-F group had
a smaller increase of plasma ADMA than the BDL-M group.
In adult rats, many studies have shown sex-related
differences in liver injury after various types of insults;19
however, similar experiments were rarely reported inalues in different experimental groups.
Sham-F BDL-F
6) (n Z 6) (n Z 6)
 7.56 62.64  4.92 56.07  4.08
 9.22* 88.15  6.27 73.01  5.25
 0.07* 0.37  0.03 0.54  0.05*y
 0.04* 0.32  0.02 0.49  0.03*
 13.45* 250.77  30.99 144.35  23.96*
 0.17 1.15  0.11 1.10  0.10
mpared with male counterpart.
male; BDL-M Z bile duct ligation-male; Sham-F Z sham control-
rginine.
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Figure 1 ADMA in the (A) liver and (B) kidney. N Z 6/group.
*p < 0.05 compared with sham control rats of the same sex. In
the liver, the BDL-M and BDL-F groups showed increased ADMA
levels. In the kidney, the ADMA level was increased in the BDL-
F group compared with the sham-F group. ADMAZ asymmetric
dimethylarginine; BDL-M Z bile duct ligation-male;
BDL-F Z bile duct ligation-female.
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Figure 2 Relative abundance of PRMT-1 in the (A) liver and
(B) kidney. N Z 6/group. Representative bands on the top of
the figure show PRMT1 (42 kDa). *p < 0.05 compared with sham
control rats of the same sex. In the liver, PRMT1 expression was
significantly higher in both BDL-M and BDL-F groups compared
with sham-M and sham-F groups. In the kidney, the PRMT-1
level was increased in the BDL-F group compared with the
sham-F group. BDL-FZ bile duct ligation-female; BDL-MZ bile
duct ligation-male; PRMT-1 Z protein arginine methyl-
transferase-1.
Gender differences of oxidative stress to cholestasis 99young rats. Our previous studies have shown different organ
insults between young and adult rats subjected to BDL.14,20
This experiment showed that the young female BDL-treated
rats had reduced liver functional impairment in comparison
with male BDL-treated rats, a finding that is consistent with
their adult counterparts.5
Although sex-related injury was noted, the pathology of
the liver and kidney did not show any significant difference
between male and female rats treated with BDL. One
possibility is that the injury was not severe enough to
induce pathologic difference. Alternatively, the duration of
injury may not have been long enough. The underlying
mechanisms responsible for sex difference remain to be
determined.
ADMA is an inhibitor of eNOS. We have previously found
plasma ADMA levels were higher in young male BDL-treated
rats, which is in line with the results in patients with
cirrhosis and in adult BDL-treated rats.10,14,21 Here, we
extended our previous findings and demonstrated that both
male and female young BDL-treated rats exhibited
increased plasma ADMA. Furthermore, female BDL-treated
rats had a smaller increase of plasma ADMA than male
BDL-treated rats. We postulate that ADMA might play a role
in the different sex susceptibility to BDL. In the rat liver
ischemia/reperfusion model, Harada et al22 reported less
hepatic injury in female rats. They postulated that an
increased circulating vasoconstrictor due to lower NO level
was the mechanism. There was evidence indicating that NO
deficiency contributes to progression of kidney damage.
Baylis23 reported that female rats were relatively moreprotected from postischemic renal failure than male rats,
and he postulated this to be due to less decline of renal
cortical NOS activity or NOS protein abundance. In our
study, the baseline creatinine levels were higher in sham
male rats in comparison with those in sham female rats.
Post hoc analysis showed that male BDL-treated rats had
increased levels of creatinine when compared with sham
male rats; however, female BDL-treated rats did not have
increased creatinine levels when compared with sham
female rats. This finding is consistent with that seen in
adult BDL-treated rats.23
Although female BDL-treated rats had a smaller increase
of plasma ADMA, tissue levels of ADMA were increased in
the liver of both male and female BDL-treated rats. In
terms of the kidney, there was a trend for female BDL-
treated rats to have higher tissue levels of ADMA in
comparison with male BDL-treated rats. Tissue ADMA itself
may not be the sole factor to account for the sex differ-
ences of BDL-induced liver and kidney injuries. L-arginine
and ADMA compete for NOS and are present in a ratio
(L-arginine:ADMA) that ensures NO homeostasis is used to
represent NO bioavailability.24 Although tissue L-arginine/
ADMA ratios were not available here, we found a trend for
female BDL-treated rats to have higher plasma L-arginine/
ADMA ratios than male BDL-treated rats. This finding might
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Figure 3 Relative quantification liver (A) CAT-1 and (B) CAT-2
transcripts was performed using the OOCT method. The inverse
OOCT was used to represent corresponding fold increases in
target transcript levels with Sham-M group. N Z 6/
group.*p < 0.05 compared with sham control rats of same the
sex. #p < 0.05 compared with male counterparts. The CAT1
level was increased in the BDL-F group compared with the
sham-F group. The CAT2 level was significantly reduced in both
the BDL-M and BDL-F groups. BDL-F Z bile duct ligation-
female; BDL-M Z bile duct ligation-male; CAT Z cationic
amino acid transporter.
100 K.-A. Chang et alpartly explain the reduced liver and kidney injuries in
female BDL-treated rats in comparison with male BDL-
treated rats.
Chronic liver diseases such as liver cirrhosis or fibrosis
are more frequently noted in men than in women and the
progression of fibrosis is also more rapid in males.25
Estrogen is thought to be the catalyst, decreasing the
proliferation of hepatic stellate cells and suppressing
hepatic collagen content, which is believed to lead to
progression of fibrosis.26 TGF-b1 is the dominant stimulus
for extracellular matrix production by stellate cells with
progression fibrosis.27 In this study, female BDL-treated rats
had less increase of TGF-b1 than male BDL-treated rats,
which is consistent with the findings in humans and in adult
rats.
The underlying mechanisms responsible for sex differ-
ences remain to be determined. Estrogen is known to play
an important role in the sexual dimorphism in liver and
renal dysfunctions in different varieties of injuries.22,28
Estrogen receptors are present in endothelial cells and NO
production via the upregulation of eNOS.19 A previous study
has shown that sex hormone levels did not significantly
differ between male and female rats at this age.29 Many
other causes or interactions need to be further clarified
such as the role of endothelin,30 the response to angio-
tensin II,31 hepatic and renal sex hormone receptors,32 livermitochondrial oxidative capacity,33 and the pattern of
growth hormone secretion.19,34
Male BDL-treated rats had a greater increase of plasma
ADMA than female BDL-treated rats. The increase in
circulating ADMA likely resulted from the increased
synthesis of ADMA (by increased PRMT1 abundance) in the
liver. Intracellular liver ADMA can be exported from the cell
to the blood by CAT 1 and CAT2, which is involved in both
cellular release and uptake of ADMA, SDMA, and L-argi-
nine.16 Although liver CAT1 expression was not altered in
BDL-treated rats, liver CAT2 was decreased in both male
and female BDL-treated rats. This finding suggests that
CAT1 and CAT2 are regulated differently in BDL-treated rat
liver. The decreased CAT2 means that CAT2 cannot be
upregulated to compensate for the increase of ADMA due to
increased liver oxidative stress.5. Conclusions
We report the sex differences in young rats treated with
BDL for the first time. In this study, we found sex-related
liver and renal injuries in young BDL-treated rats. Our
results hint at more aggressive treatment in young male
patients with cholestasis, such as biliary atresia, to reduce
liver or kidney complications.Acknowledgments
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